You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞銀窩輪》阿里連升三日後回調資金流入好倉產品 看好可留意阿里認購(21306)
較早前有指馬雲以及主席蔡崇信上季增持阿里股份,馬雲更取代軟銀成為阿里最大的單一股東。阿里本周股價自周二起連升三日,直至周五阿里曾跌穿其20天線後跌幅收窄,最終仍險守於20天線以上水平收市,收報70.9元。阿里連升三日後回調,資金顯著流入好倉產品博反彈,如投資者看好阿里可留意阿里認購(21306),行使價83.78元,24年5月到期,有效槓桿約8.1倍。相反看淡可留意阿里熊證(62669),收回價77元,行使價78.5元,24年12月到期,有效槓桿約9.9倍。 周五開市後聯想(00992)曾跌逾13%,其後跌勢喘定,最終股價下跌9.94%,收報9.24元。由於聯想股價急跌,少部分投資者趁低買入相關好倉產品,如希望博聯想股價反彈,看好可留意聯想認購(21071),行使價13.48元,24年12月到期,有效槓桿約4倍。 午後有消息指藥明系或與美議員提出一項禁止生物技術取得聯邦合約法案有關,消息即拖累藥明系股價暴瀉,藥明康德(02359)及藥明生物(02269)一度挫32%及27.8%,亦曾觸發市場調節機制。由於藥明系列股價波動,藥明相關輪證的引伸波幅亦被抽升至少約2個波幅點,而市場上藥明的相關牛證產品亦幾近被全數收回。如投資者因消息看淡藥明系列,可留意藥明熊證(62838),收回價34元,行使價35.5元,24年10月到期,有效槓桿約2.4倍。 更多窩輪牛熊資訊:瑞銀認股證牛熊證網站:http://www.ubs.com/hkwarrants 輪證教學及巿況焦點短片: https://www.youtube.com/@ubswarrantshk8566 瑞銀認股證牛熊證團隊 本產品並無抵押品。 如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。筆者為UBS AG的代表(作為證監會持牌人),並未持有相關上市公司的任何財務權益。本資料由瑞銀刊發,其並不構成買賣建議、邀請、要約或遊說。結構性產品價格可急升或急跌,投資者可能會蒙受全盤損失。過往表現並不反映將來表現。牛熊證備強制贖回機制而可能被提早終止,屆時 (i) N類牛熊證投資者將不獲發任何金額;而(ii) R類牛熊證之剩餘價值可能為零。投資前應瞭解有關風險,並諮詢專業顧問及查閱有關上市檔。UBS Securities Hong Kong Limited為結構性產品之流通量提供者,亦可能是唯一報價者或巿場參與者。(C) UBS 2024。版權所有。~ 重要聲明: 以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account